BioCatalyst

TRIESENCE (triamcinolone acetonide injectable suspension) — catalyst calendar

1 verified catalyst event(s) referencing TRIESENCE (triamcinolone acetonide injectable suspension), each linked to its official source. Verified as of 2026-09-23.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 2mo
ESTIMATED
 READOUT
A Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Sus
Phase 3 · Postoperative Ocular Inflammation, Postoperative Ocular Pain
 HROW HARROW, INC. TRIESENCE (triamcinolone acetonide injec ClinicalTrials.gov ↗
✓ Source-checked 2026-09-23
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.